What is it about?
A review of drugs in development for the treatment of non-alcoholic fatty liver disease. There are currently no drugs approved to treat this disease.
Featured Image
Why is it important?
Nonalcoholic fatty liver disease, an accumulation of fat in the liver. Almost 20% of adults may have fatty liver disease, especially obese and diabetic patients. Nonalcoholic steatohepatitis is a more severe form of nonalcoholic fatty liver disease, which can progress to more serious problems like cirrhosis. There are no current drugs approved to treat the diseas.
Read the Original
This page is a summary of: New Medications in the Treatment of Nonalcoholic Steatohepatitis, Hospital Pharmacy, March 2018, SAGE Publications,
DOI: 10.1177/0018578718763098.
You can read the full text:
Contributors
The following have contributed to this page
